@LoriMills4CA42 Lots of counterfeit out there. I almost fell victim to a scammer. There are “doctors” on x that are pushing repurposed drugs too. I called a local doctors who’s likeness was being used on X. Her office confirmed that the x user is an imposter.
Proud moment for our team and for patients across Europe.
Our first EU (German) labeling and packaging run for ANKTIVA is complete. These vials represent more than manufacturing. They mark the next step in bringing this IL-15 immunotherapy to patients with BCG-unresponsive NMIBC who previously faced limited options.
Global access continues. Unstoppable
I see the amazing revolution of PRECISION tumor-targeted radio therapy with these cancer fighting isotopes manufactured by Shine. This will replace tissue damaging current radiation therapy .
The field of antibody and peptide radio-isotope oncology is about to explode …but to protect the ALC count ( drop in NK and T cells from the radiation) we will need a solution! Guess what does that ?
Thank goodness there is one. IL-15 ..a T and NK cell growth factor to the rescue! ALC matters. Pluvicto and IL15 combo trial being planned. Unstoppable as the world of cancer therapy transforms to biologics.
$IBRX With ANKTIVA’s addition to the NCCN guidelines for papillary disease, I firmly believe the FDA has no choice but to approve the sBLA for papillary before the end of October. The data is screaming. @LoriMills4CA42@alc2022
Right to try means life!
So many need it’
My husband Thriving with #ANKTIVA and NK cell therapy, Brealyn thriving
On DC-Vax, both hard to access yet Moderna gets approved?
Cut the red tape- unleash access to these therapies!
God bless Brealyn and Amanda for sharing this journey! Life!
@MakisMedicine Mr Makis, is your [email protected] email compromised? I’m sending messages to inquire about coaching, but I think your email is compromised or a scam.